Latest News and Press Releases

Newton Biocapital entre au capital en tant que nouvel investisseur, importante participation des investisseurs historiquesLancement en 2027 d’un essai pivot de phase 2b portant sur BIOX-101 dans le...

Newton Biocapital enters as new investor, strong participation of existing investorsPivotal Phase 2b trial initiation in 2027 of BIOX-101 to treat intracerebral hemorrhage BIOX-101 may be...

Fort Myers, Fla., Dec. 04, 2025 (GLOBE NEWSWIRE) -- From viral neuroscience videos to consulting with patients nationwide, Dr. Jessica Lowe, widely known as “Doctor Brain Barbie” (Instagram/TikTok:...

BEDFORD, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spryte Medical, a pioneer in intravascular neuro imaging, announced it has received Investigational Device Exemption (IDE) approval from the U.S....

Prof Lemmens underscores large unmet medical need in intracerebral hemorrhage “Very encouraging” data from Phase 2a trial with lead asset BIOX-101 Bioxodes is preparing for a possibly registrational...

Route 92 Medical Appoints Medtech Industry Leader Pat Mackin to its Board of Directors

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI)-Powered Acute Stroke Triage Market Report 2025" report has been added to ResearchAndMarkets.com's offering.The artificial...

Wandercraft earns second FDA clearance for expanded indications of Atalante X, enabling rehab for spinal cord injury and multiple sclerosis patients.

Woburn, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Javadin™ (clonidine hydrochloride) oral...

KPC Health is pleased to announce the appointment of renowned neuroradiologist Dr. Jeffrey Farkas, MD, as Director of Neurosciences.